Back to top

vaccines: Archive

Zacks Equity Research

GSK Q1 Earnings Beat, Sales Lag, Stock Gains on Tariff Reassurance

GSK reports mixed first-quarter 2025 results. Shares rise in pre-market after it reaffirms guidance and says it is "well positioned" to handle the U.S. tariffs.

SNYPositive Net Change GSKPositive Net Change JNJPositive Net Change VIRPositive Net Change

Shaun Pruitt

Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?

Pfizer (PFE) shares spiked 3% in Tuesday's trading session as the pharmaceutical giant was able to crush its Q1 earnings expectations.

PFEPositive Net Change JNJPositive Net Change NVOPositive Net Change LLYPositive Net Change ABBVPositive Net Change

Zacks Equity Research

AZN Q1 Earnings Beat, Stock Down on Soft Sales Performance of Key Drugs

AstraZeneca reports mixed first-quarter 2025 results. The fall in pre-market is likely due to the soft sales performance of key drugs across the oncology and rare disease segments.

SNYPositive Net Change AZNPositive Net Change MRKPositive Net Change AMGNPositive Net Change

Zacks Equity Research

GSK to Report First-Quarter Earnings: Is a Beat in Store?

We expect GSK's specialty products like Cabenuva, Juluca, Dovato, Nucala, Ojjaara, Jemperli and Trelegy Ellipta to have driven first-quarter sales performance.

GSKPositive Net Change JNJPositive Net Change CTMXPositive Net Change ARGXPositive Net Change

Zacks Equity Research

Can Moderna Keep the Beat Streak Alive This Earnings Season?

When MRNA reports first-quarter earnings, investors will likely focus on pipeline updates.

MRKPositive Net Change MRNAPositive Net Change CTMXPositive Net Change ARGXPositive Net Change

Zacks Equity Research

Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut

MRK posts better-than-expected first-quarter results but trims its 2025 EPS outlook due to anticipated one-time charges.

AZNPositive Net Change MRKPositive Net Change ANIPPositive Net Change CTMXPositive Net Change

Sundeep Ganoria

Vaccine Stocks Rise on Growing Threat of Bird Flu Infections

The Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE) to develop bird flu vaccines over increasing fears of widespread transmission of the infection.

PFEPositive Net Change MRNAPositive Net Change NVAXPositive Net Change CVACPositive Net Change

Zacks Equity Research

GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP

The U.S. CDC's Advisory Committee recommends the use of GSK's pentavalent Penmenvy vaccine as part of the adolescent meningococcal vaccination schedule.

GSKPositive Net Change DVAXPositive Net Change BAYRYNegative Net Change ADMANegative Net Change

Zacks Equity Research

Vaxcyte Stock Plummets 56% in a Month: Here's the Reason

The downside comes after PCVX reports mixed results from a mid-stage study on its pneumococcal vaccine in infants.

PFEPositive Net Change ANIPPositive Net Change ETNBPositive Net Change PCVXPositive Net Change

Zacks Equity Research

ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up

Anixa Biosciences stock jumps 13% on new patent grant for its breast cancer vaccine technology in the United States.

DVAXPositive Net Change BAYRYNegative Net Change ADMANegative Net Change ANIXPositive Net Change

Sundeep Ganoria

Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes

Shares of pharma giants like PFE, J&J, AZN, MRK and ABBV decline on investor concerns that retaliatory tariffs could drive up drug prices for U.S. consumers.

JNJPositive Net Change PFEPositive Net Change MRKPositive Net Change LLYPositive Net Change AMGNPositive Net Change ABBVPositive Net Change

Zacks Equity Research

PFE Secures EU Nod for Expanded Use of RSV Vaccine Abrysvo

The latest decision makes Pfizer's Abrysvo the first RSV vaccine approved for use in non-pregnant adults under 50 years of age in the EU.

GSKPositive Net Change PFEPositive Net Change MRNAPositive Net Change

Sundeep Ganoria

Biotech Stocks Fall After Top FDA Official Quits Over Clash With RFK Jr.

The decline in biotech stocks comes after FDA official Peter Marks' resignation, citing irreconcilable differences with the new HHS Secretary.

MRNAPositive Net Change NVAXPositive Net Change SRPTPositive Net Change CRSPPositive Net Change PCVXPositive Net Change

Zacks Equity Research

GSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract Infection

The FDA approval is based on late-stage data, which shows that GSK's Blujepa is at least as effective as a leading standard treatment for uncomplicated UTIs.

GSKPositive Net Change ANIPPositive Net Change CTMXPositive Net Change ETNBPositive Net Change

Sundeep Ganoria

Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?

Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.

GSKPositive Net Change PFEPositive Net Change MRKPositive Net Change MRNAPositive Net Change